AokiHTakadaYKondoS. (2007) Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways. Mol Pharmacol72: 29–39.
2.
ChoiAMRyterSWLevineB (2013) Autophagy in human health and disease. N Engl J Med368: 651–662.
3.
CoxKHPipingasAScholeyAB (2015) Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population. J Psychopharmacol29: 642–651.
4.
Heras-SandovalDPérez-RojasJMHernández-DamiánJ. (2014) The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration. Cell Signal26: 2694–2701.
5.
JiangZGuoMShiC. (2015) Protection against cognitive impairment and modification of epileptogenesis with curcumin in a post-status epilepticus model of temporal lobe epilepsy. Neuroscience310: 362–371.
6.
KaurHPatroITikooK. (2015) Curcumin attenuates inflammatory response and cognitive deficits in experimental model of chronic epilepsy. Neurochem Int89: 40–50.
7.
LiYLiJLiS. (2015) Curcumin attenuates glutamate neurotoxicity in the hippocampus by suppression of ER stress-associated TXNIP/NLRP3 inflammasome activation in a manner dependent on AMPK. Toxicol Appl Pharmacol286: 53–63.
8.
MaitiPMannaJVeleriS. (2014) Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin. Biomed Res Int2014: 495091.
9.
McKhannGMKnopmanDSChertkowH. (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7: 263–269.
10.
OrrMEOddoS (2013) Autophagic/lysosomal dysfunction in Alzheimer’s disease. Alzheimers Res Ther5: 53.
11.
PanahiYBadeliRKaramiGR. (2015) Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder. Phytother Res29: 17–21.
12.
PanahiYRahimniaARSharafiM. (2014a) Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial. Phytother Res28: 1625–1631.
13.
PanahiYSaadatABeiraghdarF. (2014b) Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double-blind placebo-controlled trial. Phytother Res28: 1461–1467.
14.
PanahiYSahebkarAParvinS. (2012) A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications. Ann Clin Biochem49: 580–588.
15.
PuYZhangHWangP. (2013) Dietary curcumin ameliorates aging-related cerebrovascular dysfunction through the AMPK/uncoupling protein 2 pathway. Cell Physiol Biochem32: 1167–1177.
16.
SahebkarAMohammadiAAtabatiA. (2013) Curcuminoids modulate pro-oxidant-antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals. Phytother Res27: 1883–1888.
17.
SahebkarA (2014) Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytother Res28: 633–642.
SahebkarASerbanM-CUrsoniuSBanachM (2015) Effect of curcuminoids on oxidative stress: A systematic review and meta-analysis of randomized controlled trials. Journal of Functional Foods18: 898–909.
20.
WangCZhangXTengZ. (2014) Downregulation of PI3K/Akt/mTOR signaling pathway in curcumin-induced autophagy in APP/PS1 double transgenic mice. Eur J Pharmacol740: 312–320.
21.
XiaoKJiangJGuanC. (2013) Curcumin induces autophagy via activating the AMPK signaling pathway in lung adenocarcinoma cells. J Pharmacol Sci123: 102–109.
